loader2
Login Open ICICI 3-in-1 Account
Text Size
Text to Speech
Color Contrast
Pause Animations

Corona Remedies Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Corona Remedies Ltd. 03 Feb 2026 12:28 PM

Q3FY26 Quarterly Result Announced for Corona Remedies Ltd.

Pharmaceuticals company Corona Remedies announced Q3FY26 results

  • The Consolidated Revenue from Operations for Q3FY26 and 9MFY26 stood at Rs 342.42 crore and Rs 1,050.09 crore respectively.
  • Revenue of the above periods grew by 15.0% and 16.3% respectively, on YoY basis.
  • PAT for the quarter and nine months FY26 was Rs 55.56 crore and Rs 154.08 crore respectively.
  • PAT of the above periods grew by 23.7% and 30.7% respectively, on YoY basis.

Nirav K. Mehta, Managing Director & CEO, CORONA Remedies, said: “We are delighted to report a strong financial performance in Q3 and 9MFY26. Revenues for Q3 and 9MFY26 grew by 15.0% and 16.3% respectively on a YoY basis, outperforming the IPM growth. Adjusted Profit after tax for Q3 and 9MFY26 grew by 23.7% and 30.7% respectively on a YoY basis while maintaining healthy return ratios. We have been consistently delivering on our guided.

We have transformed our aspiration of growing Revenues by 15% and PAT by 20% into successful achievement. Our revenues & PAT has grown as per our aspiration in the last 3 quarters and are optimistic of maintaining similar trajectory going forward.

Our strong performance reflects the consistency of our strategy, disciplined execution and deep focus on our core therapeutic segments. By strengthening our field force, expanding our brand portfolio and maintaining a sharp focus on specialists’ prescriptions, we have continued to outperform the market while building a sustainable platform for long-term growth.

I would also like to thank the entire team at CORONA and our stakeholders for their continued support and faith in our business.”

Result PDF

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Get it on google Play Store Download on the App Store
market app